Guidance
Evidence-based recommendations on the MiniMed Paradigm Veo and Vibe and G4 PLATINUM CGM sensor-augmented pump therapy systems, which combine continuous glucose monitoring and continuous subcutaneous insulin infusion, for people with type 1 diabetes.
Is this guideline up to date?
We reviewed this guidance in January 2020 and we are updating it. See the guideline in development page for progress on the update.